News | Treatment Planning | October 18, 2019

MD Anderson and Varian Partner to Optimize Radiation Oncology Treatment

Partnership will connect participating sites to a central database to streamline review of radiation therapy treatment plans

MD Anderson and Varian Partner to Optimize Radiation Oncology Treatment

October 18, 2019 — The University of Texas MD Anderson Cancer Center and Varian announced a new strategic collaboration to develop an integrated software platform to streamline review of radiation oncology treatment plans.

The goal of the platform is to establish an efficient framework to connect participating sites to a central database, allowing MD Anderson physicians to host collaborative review sessions around treatment plans and to communicate plan changes back to physicians. As the platform matures, it has the potential to be deployed at all MD Anderson locations and across MD Anderson Cancer Network.

“Radiation oncology is a highly technical specialty that relies on the interoperability of a variety of hardware and software components,” said Albert Koong, M.D., Ph.D., professor and division head of radiation oncology at MD Anderson. “We believe the development of this unified platform with Varian will enable expansion of our radiation oncology quality standards to provide the best available care to more patients.”

Watch the VIDEO: Walk Around of a Varian Identify Image-guided Patient Positioning System

MD Anderson Cancer Network, a program of MD Anderson Cancer Center, collaborates with community hospitals and healthcare systems around the globe to provide higher quality and advanced care to patients in the communities in which they live.

In addition to the software platform, the partnership will work to develop evidence-based tools to improve the analysis of various quality measures, with a focus on:

  • Minimizing the volume of radiation dose distributed to nearby healthy organs, resulting in fewer side effects for patients;
  • Automating the comparison of treatment plans to MD Anderson and national quality criteria, enabling the development of new standard value and safety metrics; and
  • Decreasing the time needed to review radiation treatment plans, improving efficiency and expanding access.

For more information: www.varian.com, www.mdanderson.org

Related Content

Members of Congress from both sides of the aisle issued a series of oversight letters to the Centers for Medicare and Medicaid Services (CMS) in recent months to urge the Agency to adjust its proposed radiation oncology advanced alternative payment model (RO Model)

Image by whitfieldink from Pixabay

News | Radiation Oncology | November 13, 2019
November 13, 2019 — Members of Congress from both sides of the aisle issued a series of oversight letters to the...
Bladder Abdomen Pelvis image with DLCExpert
News | Artificial Intelligence | November 07, 2019
November 7, 2019 — Mirada Medical, a global leader in...
Liver cancer tumor scanning using an MRI
News | Proton Therapy | November 04, 2019
November 4, 2019 – Two new studies support and inform the use of proton radiation therapy to treat patients with hepa
Advanced Radiation Therapy Upgrades AccuBoost Digital Brachytherapy Platform
News | Brachytherapy Systems, Women's Healthcare | October 23, 2019
At the 2019 American Society for Radiation Oncology (ASTRO) annual meeting, Sept. 15-18 in Chicago, Advanced Radiation...
Low four-year rates of gastrointestinal (13.6 percent) and urologic issues (7.6 percent) suggest hypofractionated proton therapy as an alternative to traditional radiotherapy to reduce toxicity.

Low four-year rates of gastrointestinal (13.6 percent) and urologic issues (7.6 percent) suggest hypofractionated proton therapy as an alternative to traditional radiotherapy to reduce toxicity.

Feature | Prostate Cancer | October 16, 2019 | By Jeff Zagoudis
Radiation therapy is an important tool in the clinician’s armamentarium for treatment of localized, early-stage prost
Videos | Radiation Oncology | October 11, 2019
Lorraine Drapek, DNP, nurse practitioner, radiation oncology, GI service,...